The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already struggled to grow sales.

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to ...

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 ...

Download to gain expert insights and data-driven analysis from the ASCO 2025 Annual Meeting. This report covers key ...

The study will be carried out in partnership with The GOG Foundation and the European Network of Gynecological Oncological ...

Pāpāmoa retiree Marion Henriksen was meant to be travelling in Germany and Austria with a friend. Instead, she had to cancel ...

Job opportunities at the Port of Los Angeles are dwindling as President Trump's steep tariffs take a hit on global trade and a major economic engine for the regional economy.

Just in time for peak travel season, Terminix®, a Rentokil Terminix company, announced today its annual list of the Top 50 Most Bed Bug-Infested U.S. Cities, based on 2024 service data from more than ...

Tour24, the leading self-guided tour app for apartments, today announced the appointment of Mike Davis as a Chief Sales Officer. A proven sales leader with over 16 years of multifamily experience, ...

The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® ...